Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr;38(4):689-696.
doi: 10.1007/s00296-017-3875-2. Epub 2017 Nov 10.

Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature

Affiliations
Review

Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature

Shogo Matsuda et al. Rheumatol Int. 2018 Apr.

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by necrotizing vasculitis of small-sized vessels with extravascular granulomas and eosinophilic infiltration. The case of a 48-year-old Japanese woman with EGPA, who presented concurrently with subarachnoid hemorrhage (SAH) and coronary vasculitis, is reported. She initially presented with bronchial asthma, and then 8 months later she developed various symptoms caused by systemic eosinophilic vasculitis and was admitted to our hospital. Three days after admission, she started oral corticosteroid therapy, and her 2009 Five-Factor Score (FFS) was 0. However, she developed an SAH, followed by coronary vasculitis 1 day later. With extensive treatment with a combination of betamethasone, cyclophosphamide, intravenous immunoglobulin, and rituximab, her systemic vasculitis improved dramatically. This seems to be the first case of EGPA with SAH and coronary vasculitis. In previous reports of EGPA with SAH, 4 of 11 cases developed SAH as an exacerbation of systemic vasculitis during remission induction therapy. The present patient also had SAH during remission induction therapy. However, the period between bronchial asthma and SAH was only 8 months. This is the shortest among case reports of EGPA with SAH. In addition, the present patient rapidly developed coronary vasculitis. These findings suggest that EGPA causes SAH and coronary vasculitis as early complications of systemic vasculitis. In EGPA, it is necessary to pay careful attention to rapid changes of disease activity, even when the FFS indicates a good prognosis.

Keywords: Coronary vasculitis; Eosinophilic granulomatosis with polyangiitis; Five-Factor Score; Subarachnoid hemorrhage; Vasculitic stage.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Arthritis Rheum. 2007 May 15;57(4):686-93 - PubMed
    1. Medicine (Baltimore). 1984 Mar;63(2):65-81 - PubMed
    1. S Afr Med J. 1985 Oct 12;68(8):603-5 - PubMed
    1. Lupus. 2005;14(9):718-22 - PubMed
    1. Ann Allergy Asthma Immunol. 2004 Jan;92(1):80-7 - PubMed

MeSH terms

Substances

LinkOut - more resources